Xoma | XOMA - Ebitda

Stock Price
30.35
Daily Change
1.13 3.87%
Monthly
13.42%
Yearly
43.63%
Q1 Forecast
27.85

Xoma reported $2.52M in EBITDA for its fiscal quarter ending in June of 2024.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Agenus USD -10.11M 19.02M Mar/2025
Agios Pharmaceuticals USD -115.49M 10.3M Sep/2025
Ardelyx USD 6.02M 447K Dec/2025
aTyr Pharma USD 25.85M 52.43M Dec/2025
BioMarin Pharmaceutical USD -24.17M 18.91M Dec/2025
Celldex Therapeutics USD -86.34M 13.54M Dec/2025
Curis USD -12.3M 231K Sep/2023
Eli Lilly USD 7.88B 378.1M Sep/2025
Incyte USD 414.5M 92.42M Dec/2025
MacroGenics USD 21.95M 55.39M Sep/2025
Novartis USD 4.77B 1.11B Dec/2025
Novartis USD 5.84B 235M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Prothena USD -39.53M 12.25M Sep/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Xoma USD 2.52M 7.98M Jun/2024